Investor Relations

Corporate ProfileNuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge, neural-interface technologies for the neuroscience pre-clinical research market.

On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis.

Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."


Stock Quote NVTR (Common Stock) $8.53 + 0.33 (4.02%)
ExchangeNASDAQ
Volume40,324
Today's Open$8.20
Previous Close$8.20
Data as of 11/17/17 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NVTR.O.  Currently trading at $8.53 with a 52 week high of $15.00 and a 52 week low of $4.90.

Recent News

November 15, 2017

Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference

PLANO, Texas, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference.     Event: 29th Annual Piper Jaffray Healthcare Conference   Date: Tuesday, November 28, 2017  

Read More >

November 06, 2017

Nuvectra to Present at the Stifel 2017 Healthcare Conference

PLANO, Texas, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate at the Stifel 2017 Healthcare Conference in New York, NY.       Event:    Stifel 2017 Healthcare Conference Date:   Tuesday, November 14, 20

Read More >


Investor Contact

The Ruth Group
Brian Johnston
Zack Kubow
investors@nuvectramed.com

Events
DateTitle
11/28/17 4:30 p.m. ET
Nuvectra at Piper Jaffray Healthcare Conference